2 DOSAGE AND ADMINISTRATION Important Administration Instructions ADSTILADRIN is for intravesical instillation only. ADSTILADRIN is not for intravenous use, topical use, or oral administration.

Find information on the dosing and administration of ADSTILADRIN®, including instillation details. See Important Safety Info.

Oct 10, 2025 · Detailed dosage guidelines and administration information for Adstiladrin (nadofaragene firadenovec-vncg). Includes dose adjustments, warnings and precautions.

Medscape - Bladder cancer dosing for Adstiladrin (nadofaragene firadenovec), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost …

Oct 10, 2025 · ADSTILADRIN (nadofaragene firadenovec-vncg) is a non-replicating adenoviral vector-based gene therapy for intravesical instillation. It is a recombinant adenovirus serotype 5 vector …

May 4, 2023 · Dosing Limits Quantity Limit (max daily dose) [NDC Unit]: − Adstiladrin suspension 3 × 1011 viral particles (vp)/mL (20 mL single-dose vial): 4 vials every three months for four doses only …

DOSAGE AND ADMINISTRATION: Administer ADSTILADRIN by intravesical instillation only. ADSTILADRIN is not for intravenous use, topical use, or oral administration. USE IN SPECIFIC …

Dosing and Administration The recommended dose of Adstiladrin is 75 mL at a concentration of 3 x 1011 viral particles (vp)/mL instilled once every 3 months into the bladder via a urinary catheter. …

Dosage interruptions of ADSTILADRIN due to an adverse reaction occurred in 54 (34%) patients. Adverse reactions in >10% of patients that required dosage interruption included instillation site …

Nadofaragene firadenovec-vncg (ADSTILADRIN) National Drug Monograph September 2023 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist …